This is the authors' abstract. We don't add key points for this paper.
Rabies virus antigen-specific human monoclonal antibodies (MAbs) that recognized either viral glycoprotein, ribonucleoprotein, or matrix proteins were generated. Only glycoprotein-specific MAb neutralized a variety of rabies viruses and protected laboratory rodents against lethal rabies virus infection. The determinant recognized by this MAb does not appear to reside in previously defined antigenic sites of the viral glycoprotein.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dietzschold et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: